Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Strong Spending on Healthcare Deals in February

Strong Spending on Healthcare Deals in February

On the dollar side, February 2019 looks hale and hearty with a combined total of $32.7 billion. The majority of that comes from one deal, not surprisingly. GE Healthcare’s (NYSE: GE) sale of its biopharma division to Danaher Corp. (NYSE: DHR) for $21.4 billion accounts for 65% of the month’s spending. Without it, the total would be $11.3 billion—still higher than the $9.7 billion turned in a year ago. The Biotechnology sector is driving a lot of spending this years, as we noted in the story on page 1. Three of the four billion-dollar-plus deals announced in February targeted biotech companies. The fourth, at $3.4 billion, came from Johnson & Johnson’s (NYSE: JNJ) acquisition of Auris... Read More »
February Puts a Chill on Healthcare Deal Volume

February Puts a Chill on Healthcare Deal Volume

January was a fairly busy month for healthcare M&A, as regular readers already know. The 136 deals announced last month showed what results from the proverbial “January thaw.” As for February deal activity, the freeze was on. At press time, just 102 deals were on the books, down 25% compared with January and down 31% compared with February 2018, which turned in a scorching 147 deals. What’s going on? The federal government shut-down that dragged into January certainly had an effect. Some sources tell us that we’re back in the typical annual cycle, where the deal-making momentum from the previous fourth quarter spills over into January but quiets down through the rest of the first... Read More »
Health Care M&Deals, Week Ending March 1, 2019

Health Care M&Deals, Week Ending March 1, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Danaher Corporation GE Biopharma business $21,400,000,000 Roche Spark Therapeutics, Inc. $4,300,000,000 Theratechnologies Inc. Katana Biopharma Inc. $2,000,000 Sarepta Therapeutics, Inc. Myonexus Therapeutics $165,000,000 eHealth Acquirer Target Price... Read More »
Health Care M&Deals, Week Ending March 1, 2019

Health Care M&Deals, Week Ending February 22, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Merck & Co., Inc. Immune Design $300,000,000 Janssen Biotech, Inc. Collaboration on novel integrin therapeutics N/A ICON plc MolecularMD N/A eHealth Acquirer Target Price Harris Computer Systems Collain Healthcare, LLC N/A symplr API Healthcare N/A... Read More »
Health Care M&Deals, Week Ending March 1, 2019

Health Care M&Deals, Week Ending February 15, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price AbbVie, Inc. Commercialization and development rights for TNB-383B $90,000,000 Labs, MRI & Dialysis Acquirer Target Price RadNet, Inc. Kern Radiology Medical Group, Inc. N/A Private investor group U.S. Renal Care, Inc. N/A Long-Term Care Acquirer... Read More »
Health Care M&Deals, Week Ending March 1, 2019

Health Care M&A Deals, Week Ending February 8, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology     Acquirer Target Price GlaxoSmithKline plc Collaboration on M7824 $342.3 million Cullinan Pearl License to TAS6417 N/A Galapagos NV Collaboration on fibrotic disease therapies N/A Genentech, Inc. Global rights to IL-15 cytokine therapeutics $120,000,000 eHealth... Read More »